81% Lower Rate of Chronic Lymphedema than Circumference Monitoring
This recent meta-analysis confirms that routine monitoring for early detection of lymphedema using ImpediMed’s L-Dex® technology, combined with early intervention, cuts the relative rate of chronic breast cancer-related lymphedema by 81% when compared to circumference monitoring.